Paradi Mirmirani, a volunteer associate professor at UCSF, told SFGATE in an email that the study found hair loss was "strongest" in patients using higher doses of GLP-1s to treat obesity or for rapid weight loss but less common in patients taking lower doses of GLP-1s to treat Type 2 diabetes
The trial outcomes demonstrated that 28 weeks after beginning the medication, individuals on the drug lost an average of 13% of their body weight, while those on the placebo gained 1.5%
For the vast majority of people, morning dosing produces the best results with the fewest complications
Goldenberg RM, Gilbert JD, Hramiak IM, Woo VC, Zinman B (2019) Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: the STOP DKA protocol
User Experiences and Testimonials Positive Outcomes Many users share positive feedback about Melanotan II, particularly regarding its ability to provide a rich, natural-looking tan with little to no UV exposure